2017年 6月 14日
EMERGO SUMMARY OF KEY POINTS:
Medical device market regulators at the Food and Drug Administration have issued a new list of reusable medical devices for which validated Instructions for Use as well as validation data for cleaning and sterilization will be required for 510(k) submissions.
The new list and requirements are part of the FDA’s ongoing efforts to comply with the 21st Century Cures Act of 2016. The agency published guidance on required validation methods for reusable devices in 2015; that guidance now also applies to the new list of reusables.
The FDA’s new list includes 11 device types and associated product codes for which instructions for use and validation data are now necessary in order to determine Substantial Equivalence:
US regulators view these devices as posing high risk of infection as well as inadequate performance in patients without stronger requirements for reprocessing. Expanding its 2015 reprocessing guidance to include the devices listed above will help mitigate these risks, states the FDA.
FDA 510(k) applicants whose reusable devices are identified in the new list must begin providing validation data in their submissions starting August 8, 2017.